Jacques Mardoukh

der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).

I. Bar-Am, I. Yaniv, R. Zaizov, 2003, Cancer letters.

Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome

S. Izraeli, H. Tamary, I. Geron, 2021, Pediatric blood & cancer.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

I. Yaniv, S. Avigad, J. Kapelushnik, 2010, The American journal of pathology.

Short Telomeres: A Novel Potential Predictor of Relapse in Ewing Sarcoma

I. Yaniv, S. Avigad, J. Issakov, 2007, Clinical Cancer Research.

Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel

I. Bar-Am, I. Yaniv, I. Cohen, 2004, British journal of haematology.

Reduced levels of miR‐34a in neuroblastoma are not caused by mutations in the TP53 binding site

Abraham Weizman, I. Yaniv, S. Avigad, 2009, Genes, chromosomes & cancer.

Distinct cytogenetic pathways of advanced‐stage neuroblastoma tumors, detected by spectral karyotyping

M. Feinmesser, I. Bar-Am, I. Yaniv, 2002, Genes, chromosomes & cancer.